Age is among the most important factors that contribute to successful treatment of acute lymphoblastic leukemia (ALL). Studies have suggested that children with ALL have far better outcomes than adults, but the reasons for this trend are still not fully understood. One possible explanation could be body size, since pharmacokinetics might be different for smaller children and larger adults. Body size does seem to matter among patients in the same age group.
Go to Previous Page
Go to Next Page